 | • レポートコード：MRC2-11QY04064 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は視神経膠腫のグローバル市場について調査・分析したレポートです。種類別（神経学的検査、コンピューター断層撮影（CT）、磁気共鳴画像法（MRI）、生検）市場規模、用途別（病院＆クリニック、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別視神経膠腫の競争状況、市場シェア ・世界の視神経膠腫市場：種類別市場規模 2015年-2020年（神経学的検査、コンピューター断層撮影（CT）、磁気共鳴画像法（MRI）、生検） ・世界の視神経膠腫市場：種類別市場規模予測 2021年-2026年（神経学的検査、コンピューター断層撮影（CT）、磁気共鳴画像法（MRI）、生検） ・世界の視神経膠腫市場：用途別市場規模 2015年-2020年（病院＆クリニック、診断センター） ・世界の視神経膠腫市場：用途別市場規模予測 2021年-2026年（病院＆クリニック、診断センター） ・北米の視神経膠腫市場分析：米国、カナダ ・ヨーロッパの視神経膠腫市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの視神経膠腫市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の視神経膠腫市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの視神経膠腫市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biocompare、Bio-Rad Laboratories、Miltenyi Biotec、BioLegend、Becton, Dickinson And Company、Beckman Coulter、Merck、ImmunoReagents、Thermo Fisher Scientific ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the optic chiasm, where the left and right optic nerves cross. They are also referred to as optic glioma or juvenile pilocytic astrocytoma. Optic nerve glioma is a rare kind of cancer that’s typically slow growing and found in children. It is rarely found in individuals over the age of 20. It has also been associated with the genetic disorder neurofibromatosis type 1, or NF1.
Treatment for these cancers is best done by a multidisciplinary treatment team. Surgery and radiation therapy are two possible ways of treating optic nerve glioma. Surgery may be performed if doctors believe they can use it to completely remove the tumor. Alternately, if the tumor is not completely removable, surgeons may remove parts of it to help relieve pressure in the skull. Radiation therapy can be done before surgery to shrink the tumor before doctors it. Alternately, it may be done after surgery to kill any remaining cancer cells. Radiation therapy involves using a machine to aim high-energy rays at the site of the tumor. Chemotherapy uses medications to kill cancer cells. This is particularly useful if the cancer has spread to other parts of the brain. Corticosteroids may be administered to reduce swelling in the skull.
Market Analysis and Insights: Global Optic Nerve Glioma Market
The global Optic Nerve Glioma market size is projected to reach US$ 328.5 million by 2026, from US$ 319.5 million in 2020, at a CAGR of 2.6%% during 2021-2026.
Global Optic Nerve Glioma Scope and Market Size
Optic Nerve Glioma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Optic Nerve Glioma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Biocompare
Bio-Rad Laboratories
Miltenyi Biotec
BioLegend
Becton, Dickinson And Company
Beckman Coulter
Merck
ImmunoReagents
Thermo Fisher Scientific
Market segment by Type, the product can be split into
Neurological Exam
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Biopsy
Market segment by Application, split into
Hospitals & Clinics
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Optic Nerve Glioma Revenue
1.4 Market by Type
1.4.1 Global Optic Nerve Glioma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Neurological Exam
1.4.3 Computed Tomography (CT)
1.4.4 Magnetic Resonance Imaging (MRI)
1.4.5 Biopsy
1.5 Market by Application
1.5.1 Global Optic Nerve Glioma Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Optic Nerve Glioma Market Perspective (2015-2026)
2.2 Global Optic Nerve Glioma Growth Trends by Regions
2.2.1 Optic Nerve Glioma Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Optic Nerve Glioma Historic Market Share by Regions (2015-2020)
2.2.3 Optic Nerve Glioma Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Optic Nerve Glioma Market Growth Strategy
2.3.6 Primary Interviews with Key Optic Nerve Glioma Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Optic Nerve Glioma Players by Market Size
3.1.1 Global Top Optic Nerve Glioma Players by Revenue (2015-2020)
3.1.2 Global Optic Nerve Glioma Revenue Market Share by Players (2015-2020)
3.1.3 Global Optic Nerve Glioma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Optic Nerve Glioma Market Concentration Ratio
3.2.1 Global Optic Nerve Glioma Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Optic Nerve Glioma Revenue in 2019
3.3 Optic Nerve Glioma Key Players Head office and Area Served
3.4 Key Players Optic Nerve Glioma Product Solution and Service
3.5 Date of Enter into Optic Nerve Glioma Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Optic Nerve Glioma Historic Market Size by Type (2015-2020)
4.2 Global Optic Nerve Glioma Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Optic Nerve Glioma Market Size by Application (2015-2020)
5.2 Global Optic Nerve Glioma Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Optic Nerve Glioma Market Size (2015-2020)
6.2 Optic Nerve Glioma Key Players in North America (2019-2020)
6.3 North America Optic Nerve Glioma Market Size by Type (2015-2020)
6.4 North America Optic Nerve Glioma Market Size by Application (2015-2020)
7 Europe
7.1 Europe Optic Nerve Glioma Market Size (2015-2020)
7.2 Optic Nerve Glioma Key Players in Europe (2019-2020)
7.3 Europe Optic Nerve Glioma Market Size by Type (2015-2020)
7.4 Europe Optic Nerve Glioma Market Size by Application (2015-2020)
8 China
8.1 China Optic Nerve Glioma Market Size (2015-2020)
8.2 Optic Nerve Glioma Key Players in China (2019-2020)
8.3 China Optic Nerve Glioma Market Size by Type (2015-2020)
8.4 China Optic Nerve Glioma Market Size by Application (2015-2020)
9 Japan
9.1 Japan Optic Nerve Glioma Market Size (2015-2020)
9.2 Optic Nerve Glioma Key Players in Japan (2019-2020)
9.3 Japan Optic Nerve Glioma Market Size by Type (2015-2020)
9.4 Japan Optic Nerve Glioma Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Optic Nerve Glioma Market Size (2015-2020)
10.2 Optic Nerve Glioma Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Optic Nerve Glioma Market Size by Type (2015-2020)
10.4 Southeast Asia Optic Nerve Glioma Market Size by Application (2015-2020)
11 India
11.1 India Optic Nerve Glioma Market Size (2015-2020)
11.2 Optic Nerve Glioma Key Players in India (2019-2020)
11.3 India Optic Nerve Glioma Market Size by Type (2015-2020)
11.4 India Optic Nerve Glioma Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Optic Nerve Glioma Market Size (2015-2020)
12.2 Optic Nerve Glioma Key Players in Central & South America (2019-2020)
12.3 Central & South America Optic Nerve Glioma Market Size by Type (2015-2020)
12.4 Central & South America Optic Nerve Glioma Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Biocompare
13.1.1 Biocompare Company Details
13.1.2 Biocompare Business Overview
13.1.3 Biocompare Optic Nerve Glioma Introduction
13.1.4 Biocompare Revenue in Optic Nerve Glioma Business (2015-2020))
13.1.5 Biocompare Recent Development
13.2 Bio-Rad Laboratories
13.2.1 Bio-Rad Laboratories Company Details
13.2.2 Bio-Rad Laboratories Business Overview
13.2.3 Bio-Rad Laboratories Optic Nerve Glioma Introduction
13.2.4 Bio-Rad Laboratories Revenue in Optic Nerve Glioma Business (2015-2020)
13.2.5 Bio-Rad Laboratories Recent Development
13.3 Miltenyi Biotec
13.3.1 Miltenyi Biotec Company Details
13.3.2 Miltenyi Biotec Business Overview
13.3.3 Miltenyi Biotec Optic Nerve Glioma Introduction
13.3.4 Miltenyi Biotec Revenue in Optic Nerve Glioma Business (2015-2020)
13.3.5 Miltenyi Biotec Recent Development
13.4 BioLegend
13.4.1 BioLegend Company Details
13.4.2 BioLegend Business Overview
13.4.3 BioLegend Optic Nerve Glioma Introduction
13.4.4 BioLegend Revenue in Optic Nerve Glioma Business (2015-2020)
13.4.5 BioLegend Recent Development
13.5 Becton, Dickinson And Company
13.5.1 Becton, Dickinson And Company Company Details
13.5.2 Becton, Dickinson And Company Business Overview
13.5.3 Becton, Dickinson And Company Optic Nerve Glioma Introduction
13.5.4 Becton, Dickinson And Company Revenue in Optic Nerve Glioma Business (2015-2020)
13.5.5 Becton, Dickinson And Company Recent Development
13.6 Beckman Coulter
13.6.1 Beckman Coulter Company Details
13.6.2 Beckman Coulter Business Overview
13.6.3 Beckman Coulter Optic Nerve Glioma Introduction
13.6.4 Beckman Coulter Revenue in Optic Nerve Glioma Business (2015-2020)
13.6.5 Beckman Coulter Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Optic Nerve Glioma Introduction
13.7.4 Merck Revenue in Optic Nerve Glioma Business (2015-2020)
13.7.5 Merck Recent Development
13.8 ImmunoReagents
13.8.1 ImmunoReagents Company Details
13.8.2 ImmunoReagents Business Overview
13.8.3 ImmunoReagents Optic Nerve Glioma Introduction
13.8.4 ImmunoReagents Revenue in Optic Nerve Glioma Business (2015-2020)
13.8.5 ImmunoReagents Recent Development
13.9 Thermo Fisher Scientific
13.9.1 Thermo Fisher Scientific Company Details
13.9.2 Thermo Fisher Scientific Business Overview
13.9.3 Thermo Fisher Scientific Optic Nerve Glioma Introduction
13.9.4 Thermo Fisher Scientific Revenue in Optic Nerve Glioma Business (2015-2020)
13.9.5 Thermo Fisher Scientific Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Optic Nerve Glioma Key Market Segments
Table 2. Key Players Covered: Ranking by Optic Nerve Glioma Revenue
Table 3. Ranking of Global Top Optic Nerve Glioma Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Optic Nerve Glioma Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Neurological Exam
Table 6. Key Players of Computed Tomography (CT)
Table 7. Key Players of Magnetic Resonance Imaging (MRI)
Table 8. Key Players of Biopsy
Table 9. Global Optic Nerve Glioma Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Optic Nerve Glioma Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Optic Nerve Glioma Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Optic Nerve Glioma Market Share by Regions (2015-2020)
Table 13. Global Optic Nerve Glioma Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Optic Nerve Glioma Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Optic Nerve Glioma Market Growth Strategy
Table 19. Main Points Interviewed from Key Optic Nerve Glioma Players
Table 20. Global Optic Nerve Glioma Revenue by Players (2015-2020) (Million US$)
Table 21. Global Optic Nerve Glioma Market Share by Players (2015-2020)
Table 22. Global Top Optic Nerve Glioma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Optic Nerve Glioma as of 2019)
Table 23. Global Optic Nerve Glioma by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Optic Nerve Glioma Product Solution and Service
Table 26. Date of Enter into Optic Nerve Glioma Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Optic Nerve Glioma Market Size by Type (2015-2020) (Million US$)
Table 29. Global Optic Nerve Glioma Market Size Share by Type (2015-2020)
Table 30. Global Optic Nerve Glioma Revenue Market Share by Type (2021-2026)
Table 31. Global Optic Nerve Glioma Market Size Share by Application (2015-2020)
Table 32. Global Optic Nerve Glioma Market Size by Application (2015-2020) (Million US$)
Table 33. Global Optic Nerve Glioma Market Size Share by Application (2021-2026)
Table 34. North America Key Players Optic Nerve Glioma Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Optic Nerve Glioma Market Share (2019-2020)
Table 36. North America Optic Nerve Glioma Market Size by Type (2015-2020) (Million US$)
Table 37. North America Optic Nerve Glioma Market Share by Type (2015-2020)
Table 38. North America Optic Nerve Glioma Market Size by Application (2015-2020) (Million US$)
Table 39. North America Optic Nerve Glioma Market Share by Application (2015-2020)
Table 40. Europe Key Players Optic Nerve Glioma Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Optic Nerve Glioma Market Share (2019-2020)
Table 42. Europe Optic Nerve Glioma Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Optic Nerve Glioma Market Share by Type (2015-2020)
Table 44. Europe Optic Nerve Glioma Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Optic Nerve Glioma Market Share by Application (2015-2020)
Table 46. China Key Players Optic Nerve Glioma Revenue (2019-2020) (Million US$)
Table 47. China Key Players Optic Nerve Glioma Market Share (2019-2020)
Table 48. China Optic Nerve Glioma Market Size by Type (2015-2020) (Million US$)
Table 49. China Optic Nerve Glioma Market Share by Type (2015-2020)
Table 50. China Optic Nerve Glioma Market Size by Application (2015-2020) (Million US$)
Table 51. China Optic Nerve Glioma Market Share by Application (2015-2020)
Table 52. Japan Key Players Optic Nerve Glioma Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Optic Nerve Glioma Market Share (2019-2020)
Table 54. Japan Optic Nerve Glioma Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Optic Nerve Glioma Market Share by Type (2015-2020)
Table 56. Japan Optic Nerve Glioma Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Optic Nerve Glioma Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Optic Nerve Glioma Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Optic Nerve Glioma Market Share (2019-2020)
Table 60. Southeast Asia Optic Nerve Glioma Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Optic Nerve Glioma Market Share by Type (2015-2020)
Table 62. Southeast Asia Optic Nerve Glioma Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Optic Nerve Glioma Market Share by Application (2015-2020)
Table 64. India Key Players Optic Nerve Glioma Revenue (2019-2020) (Million US$)
Table 65. India Key Players Optic Nerve Glioma Market Share (2019-2020)
Table 66. India Optic Nerve Glioma Market Size by Type (2015-2020) (Million US$)
Table 67. India Optic Nerve Glioma Market Share by Type (2015-2020)
Table 68. India Optic Nerve Glioma Market Size by Application (2015-2020) (Million US$)
Table 69. India Optic Nerve Glioma Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Optic Nerve Glioma Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Optic Nerve Glioma Market Share (2019-2020)
Table 72. Central & South America Optic Nerve Glioma Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Optic Nerve Glioma Market Share by Type (2015-2020)
Table 74. Central & South America Optic Nerve Glioma Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Optic Nerve Glioma Market Share by Application (2015-2020)
Table 76. Biocompare Company Details
Table 77. Biocompare Business Overview
Table 78. Biocompare Product
Table 79. Biocompare Revenue in Optic Nerve Glioma Business (2015-2020) (Million US$)
Table 80. Biocompare Recent Development
Table 81. Bio-Rad Laboratories Company Details
Table 82. Bio-Rad Laboratories Business Overview
Table 83. Bio-Rad Laboratories Product
Table 84. Bio-Rad Laboratories Revenue in Optic Nerve Glioma Business (2015-2020) (Million US$)
Table 85. Bio-Rad Laboratories Recent Development
Table 86. Miltenyi Biotec Company Details
Table 87. Miltenyi Biotec Business Overview
Table 88. Miltenyi Biotec Product
Table 89. Miltenyi Biotec Revenue in Optic Nerve Glioma Business (2015-2020) (Million US$)
Table 90. Miltenyi Biotec Recent Development
Table 91. BioLegend Company Details
Table 92. BioLegend Business Overview
Table 93. BioLegend Product
Table 94. BioLegend Revenue in Optic Nerve Glioma Business (2015-2020) (Million US$)
Table 95. BioLegend Recent Development
Table 96. Becton, Dickinson And Company Company Details
Table 97. Becton, Dickinson And Company Business Overview
Table 98. Becton, Dickinson And Company Product
Table 99. Becton, Dickinson And Company Revenue in Optic Nerve Glioma Business (2015-2020) (Million US$)
Table 100. Becton, Dickinson And Company Recent Development
Table 101. Beckman Coulter Company Details
Table 102. Beckman Coulter Business Overview
Table 103. Beckman Coulter Product
Table 104. Beckman Coulter Revenue in Optic Nerve Glioma Business (2015-2020) (Million US$)
Table 105. Beckman Coulter Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Product
Table 109. Merck Revenue in Optic Nerve Glioma Business (2015-2020) (Million US$)
Table 110. Merck Recent Development
Table 111. ImmunoReagents Business Overview
Table 112. ImmunoReagents Product
Table 113. ImmunoReagents Company Details
Table 114. ImmunoReagents Revenue in Optic Nerve Glioma Business (2015-2020) (Million US$)
Table 115. ImmunoReagents Recent Development
Table 116. Thermo Fisher Scientific Company Details
Table 117. Thermo Fisher Scientific Business Overview
Table 118. Thermo Fisher Scientific Product
Table 119. Thermo Fisher Scientific Revenue in Optic Nerve Glioma Business (2015-2020) (Million US$)
Table 120. Thermo Fisher Scientific Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Optic Nerve Glioma Market Share by Type: 2020 VS 2026
Figure 2. Neurological Exam Features
Figure 3. Computed Tomography (CT) Features
Figure 4. Magnetic Resonance Imaging (MRI) Features
Figure 5. Biopsy Features
Figure 6. Global Optic Nerve Glioma Market Share by Application: 2020 VS 2026
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Optic Nerve Glioma Report Years Considered
Figure 10. Global Optic Nerve Glioma Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Optic Nerve Glioma Market Share by Regions: 2020 VS 2026
Figure 12. Global Optic Nerve Glioma Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Optic Nerve Glioma Market Share by Players in 2019
Figure 15. Global Top Optic Nerve Glioma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Optic Nerve Glioma as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Optic Nerve Glioma Revenue in 2019
Figure 17. North America Optic Nerve Glioma Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Optic Nerve Glioma Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Optic Nerve Glioma Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Optic Nerve Glioma Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Optic Nerve Glioma Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Optic Nerve Glioma Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Optic Nerve Glioma Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
悪性神経膠腫の世界市場（～2026年） Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers. In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and p…- 悪性神経膠腫治療の世界市場（～2026年） Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers. In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and p…
- 悪性神経膠腫治療薬の世界市場（～2026年） Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers. In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and p…
- 神経修復の世界市場（～2026年） Neuroregeneration refers to the regrowth or repair of nervous tissues, cells or cell products. Such mechanisms may include generation of new neurons, glia, axons, myelin, or synapses. Neuroregeneration differs between the peripheral nervous system (PNS) and the central nervous system (CNS) by the fu…
- 神経修復・再生の世界市場（～2026年） Nerve repair and regeneration is the abbreviation of nerve repair surgery, which is an important part of the comprehensive treatment of neurorestoration and an important treatment for enhancing the recovery of nervous system function. The presence of strong product pipeline of major multinational co…